OOIR: Observatory of International Research

Papers

(The TQCC of Biosocieties is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	14
Discipline for pleasure: a new governmentality of HIV prevention	12
Sexual health as surplus: the marketization of PrEP in Taiwan	12
Deploying nationalist discourses to reduce sex-, gender- and HIV-related stigma in Thailand	12
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	11
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence	10
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time	10
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation	10
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies	9
Mapping ‘bio geo-body’ of Southeast Asia: strategic differentiation and identification of ethnic identity in Vietnam and Singapore	9
Genome editing: From bioethics to biopolitics	8
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	7
Molecular sovereignties: patients, genomes, and the enduring biocoloniality of intellectual property	7
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies	7
Bleak Biopolitics and Abolitionist Aspirations: Recent Books on Race	7
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities	6
The evolution, devolution and distribution of UK Biometric Imaginaries	6
Challenges in public policy for the implementation of pharmacogenetic tests in Europe	6
Beyond secrecy and openness: telling a relational story about children’s best interests in donor-conceived families	6
“The elephant in the room”: social responsibility in the production of sociogenomics research	6
Openness in donor conception families	5
Post-identifiability in changing sociotechnological genomic data environments	5
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar	5
Epistemology of the side effect: anecdote and evidence in the digital age	5
Psychedelic innovations and the crisis of psychopharmacology	4

It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’	4
Pharmaceutical innovation and its crisis: drug markets, screening, and the dialectics of value	4
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices	4
Beyond controversies in child mental health: negotiating autism and ADHD diagnosis in France and Brazil	4
Making death through producing life: Necrovalue and the political economy of death	4
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	4
Value-creation in the health data domain: a typology of what health data help us do	3
Allostatic load: historical origins, promises and costs of a recent biosocial approach	3
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building	3
Correction to: The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	3
Negotiating the necessity of biomedical animal use through relations with vulnerability	3